summary: Targeted (amplicon) reduced representation bisulfite sequencing (RRBS) data for HGSOC PH039 PDXs at baseline and treated with cycles of 100 mg/kg niraparib for 21 days for four treatment rounds.

overall_design: RBBS data of 12 samples: Niraparib arm (n=8) with up to four cycles of treatment or source tumor arm (n=4) with 0-5 passages in absence of drug.


title: Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support

status: Public on Jun 16 2021

city: Rochester

first: Cameron

last: Baker

state: NY

address: 601 Elmwood Ave

country: USA

institute: University of Rochester

type: Expression profiling by high throughput sequencing

summary: Bone marrow mesenchymal stromal cells (MSCs) constitute one of the important components of the hematopoietic microenvironmental niche. There is in vitro evidence that marrow MSCs are able to support leukemia progenitor cell proliferation and survival and provide resistance to cytotoxic therapies.  How MSCs from leukemia marrow differ from normal counterparts and how they are influenced by the presence of leukemia stem, and progenitor cells are still incompletely understood.  In this work, we compared normal donor (ND) and acute myelogenous leukemia (AML) derived MSCs and found that AML-MSCs had increased adipogenic potential with improved ability to support survival of leukemia progenitor cells. To identify underlying changes, RNA-Seq analysis was performed.  Gene ontology and pathway analysis revealed adipogenesis to be among the set of altered biological pathways dysregulated in AML-MSCs as compared to ND-MSCs.  Expression of both SOX9 and EGR2 was decreased in AML-MSCs as compared to ND-MSCs.  Increasing expression of SOX9 decreased adipogenic potential of AML-MSCs and decreased their ability to support AML progenitor cells.  These findings suggest that AML-MSCs possess adipogenic potential which may enhance support of leukemia progenitor cells.

overall_design: Three bone marrow derived MSC samples isolated from three different AML patients and three bone marrow derived MSC isolated from three different ND control donors resulted in reduction of hematopoietic stem cell content.

first: Mitra

last: Azadniv

first: Jason

middle: R

last: Myers

first: Helene

last: McMurray

first: Naxin

last: Guo

first: Phil

last: Rock

first: Myra

middle: L

last: Coppage

first: John

last: Ashton

first: Michael

middle: W

last: Becker

first: Laura

middle: M

last: Calvi

first: Jane

last: Liesveld


title: WhiB4 is required for the reactivation of latent infection of Mycobacterium marinum in zebrafish

city: Shanghai

first: Chen

last: Lin

address: NO.2005 Songhu road

country: China

institute: Fudan university

type: Genome binding/occupancy profiling by high throughput sequencing

summary: This SuperSeries is composed of the SubSeries listed below.

sample_organism:
Mycobacterium marinum
Danio rerio

platform_organism:
Mycobacterium marinum
Danio rerio

overall_design: Refer to individual Series


title: WhiB4 is required for the reactivation of latent infection of Mycobacterium marinum in zebrafish [ChIP-Seq]

summary: Granulomas are the pathological hallmark of tuberculosis (TB). In individuals latently infected with Mycobacterium tuberculosis (M. tb), the bacteria are thought to reside within the granulomas in a nonreplicating dormant state due to the lack of oxygen and nutrients. However, a portion of these individuals will develop active TB and little is known on the bacterial mechanisms/factors involved in this process. In this study, we found that WhiB4, an oxygen sensor and a transcription factor, plays a critical role in disease progression and reactivation of Mycobacterium marinum (M. marinum) infection in zebrafish. We show that the whiB4 mutant of M. marinum caused latent infection in adult zebrafish, which is characterized by the stable bacterial loads, constant number of non-necrotized granulomas in fewer organs, and reduced immune responses compared to zebrafish infected with the wild type bacteria or the complemented strain. The mutant bacteria in zebrafish were also less responsive to antibiotic treatments. Moreover, the whiB4 mutant was defective in resuscitation from hypoxia-induced dormancy and that the DosR regulon was dysregulated in the mutant. Taken together, our results suggest that WhiB4 is a major driver of reactivation from latent infection and that WhiB4 is an attractive target for the development of novel therapeutics, which may help to prevent the reactivation of latent infection thereby reducing the incidences of active TB.

overall_design: Examination of binding DNA of WhiB4 in wild type Mycobacteria marinum 1218R overexpressed WhiB4 in logarithmic phase, 7 days' hypoxia and 0.5hours' reaeration

first: Lu

last: Zhang

first: Jun

last: Liu


title: Effect of age on human retinal pigment epithelium (RPE) transcriptome

city: Amsterdam

first: Joe

last: Butler

address: Meibergdreef 9

department: Infectious diseases

country: Netherlands

institute: Amsterdam UMC

summary: We hypotheize that the human RPE undergoes transcriptional changes with increasing age. To test this hypothesis we isolated RPE from human donors with different ages and performed high-throughput RNA sequencing.

overall_design: We isolated the RPE (macular and periphery combined) of one eye from 13 human donors. Donors had no reported retinal pathology and ranged in age from 31 to 93. RNAseq was performed and then for every gene we analysed the correlation between the gene's expression and age.

first: J

first: L

last: Paraoan


title: WhiB4 is required for the reactivation of latent infection of Mycobacterium marinum in zebrafish [bacteria RNA seq]

overall_design: mRNA profiles of whiB4 mutant and wild type Mycobacteria marinum 1218R in 7 days' hypoxia and 0/0.5/4/24/48hours' reaeration


title: Rprd Proteins Control Transcription In Human Cells

city: BIRMINGHAM

first: Hurmuz

last: CEYLAN

address: School of Biosciences, University of Birmingham,, Edgbaston B15 2TT

country: United Kingdom

institute: University of Birmingham

summary: Regulation of transcription is an essential process that allows the cell to respond to various internal and external signals. RNA Polymerase II (Pol II) activity is controlled by a number of factors which bind to the C-terminal domain (CTD) of its largest subunit, RPB1, and stimulate or supress RNA synthesis. Here, we demonstrate that members of the RPRD family of CTD-interacting proteins, RPRD1A, RPRD1B and RPRD2, act as negative regulators of transcription. We show they form mutually exclusive complexes with Pol II, coordinating this way their roles in transcription control. Our data indicate that the main alterations in gene expression patterns are driven by RPRD2, which results in further consequences during the cellular stress response, cell cycle and cell growth.

sample_organism:
Saccharomyces cerevisiae
Homo sapiens

platform_organism:
Saccharomyces cerevisiae
Homo sapiens

overall_design: Investigation the role of RPRD proteins on newly synthesized RNA

first: Kinga

last: Winczura

last: Ceylan

first: Monika

last: Sledziowska

first: Matt

last: Jones

first: Holly

last: Fagarasan

first: Jianming

last: Wang

first: Marco

last: Saporano

first: Daniel

last: Hebenstreit

first: Roland

last: Arnold

first: Pawel

last: Grzechnik


title: Hypodiploidy in a pediatric patient of T-cell acute lymphoblastic leukemia: a case report

city: Lublin

first: Martyna

last: Stefaniak

address: Antoniego Gębali 6

department: Laboratory of Genetics Diagnostics

country: Poland

institute: Medical University of Lublin

type: Genome variation profiling by genome tiling array

summary: We report clinical and genetic findings of a 14-year-old male with T-cell acute lymphoblastic leukemia with low-hypodiploidy. The medical history included neck pain for a month, facial nerve palsy on the right side for 6 days, fever, drowsiness, and weakness for 3 days, vomiting, diarrhea for 1 day. The physical examination presented features of hypovolemia, palsy of the facial nerve on the right side, enlarged lymph nodes, hepatosplenomegaly, sore throat, and petechiae of the skin. Radiological images indicated lesions of different organs. Bone marrow biopsy confirmed precursor T-ALL. In the FISH tests, KMT2A and BCR/ABL1 rearrangements were not observed. GTG banding revealed 3 cell clones, which confirmed the hypodiploidy. Multiplex RT-qPCR was performed. STIL/TAL1 (del1p32) gene rearrangement was found in the blast cells. Additional tests were performed using the CytoScan HD microarray technique. Molecular karyotype did not reveal hypodiploidy, but identified other abnormalities such as duplication of chromosomal regions: 4q25q35.2, 6p23.3p11.1 and 8p23.3q24.21, and the loss of heterozygosity of short arm chromosome 9. In two regions of the chromosome biallelic deletions were found at 9p21.3, including the CDKN2A, CDKN2B, IFNA1, MTAP genes and at 10q23.31, containing PTEN. The child died 9 days after diagnosis. Bone marrow biopsy, GTG banding, FISH techniques, and molecular karyotyping were used to make an accurate diagnosis. This case documents a rapid progression of the disease and unfavorable results of T-cell acute lymphoblastic leukemia with hypodiploidy.

overall_design: In this study we report the case of a 14-year-old male with T-cell acute lymphoblastic leukemia with low-hypodiploidy. Multiplex RT-qPCR and CytoScan HD microarray technique were performed. STIL/TAL1 (del1p32) gene rearrangement was found in the blast cells. Molecular karyotype did not reveal hypodiploidy, but identified other abnormalities such as duplication of chromosomal regions: 4q25q35.2, 6p23.3p11.1 and 8p23.3q24.21, and the loss of heterozygosity of short arm chromosome 9. In two regions of the chromosome biallelic deletions were found at 9p21.3, including the CDKN2A, CDKN2B, IFNA1, MTAP genes and at 10q23.31, containing PTEN. Bone marrow biopsy, GTG banding, FISH techniques, and molecular karyotyping were used to make an accurate diagnosis.

last: Lejman


title: Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1G93A murine model of amyotrophic lateral sclerosis in a sex-dependent manner

city: New York

first: Paul

middle: Francis

last: Gugger

address: 435 E 30th St

department: Medicine

institute: NYU Langone Health

summary: Burgeoning evidence highlights seminal roles for microglia in the pathogenesis of neurodegenerative diseases including amyotrophic lateral sclerosis (ALS). The receptor for advanced glycation end products (RAGE) binds ligands relevant to ALS that accumulate in the diseased spinal cord and RAGE has been previously implicated in the progression of ALS pathology. We generated a novel mouse model to temporally delete Ager from microglia in the murine SOD1G93A model of ALS. Microglia Ager deficient SOD1G93A mice and controls were examined for changes in survival, motor function, gliosis, motor neuron numbers, and transcriptomic analyses of lumbar spinal cord. Furthermore, we examined bulk-RNA-sequencing transcriptomic analyses of human ALS cervical spinal cord. Transcriptomic analysis of human cervical spinal cord reveals a range of AGER expression in ALS patients, which was negatively correlated with age at disease onset and death or tracheostomy. The degree of AGER expression related to differential expression of pathways involved in extracellular matrix, lipid metabolism, and intercellular communication. Microglia display increased RAGE immunoreactivity in the spinal cords of high AGER expressing patients and in the SOD1G93A murine model of ALS vs. respective controls. We demonstrate that microglia Ager deletion at the age of symptomatic onset, day 90, in SOD1G93A mice extends survival in male but not female mice. Critically, many of the pathways identified in human ALS patients that accompanied increased AGER expression were significantly ameliorated by microglia Ager deletion in male SOD1G93A mice. Our results indicate that microglia RAGE disrupts communications with cell types including astrocytes and neurons, intercellular communication pathways that divert microglia from a homeostatic to an inflammatory and tissue-injurious program. In totality, microglia RAGE contributes to the progression of SOD1G93A murine pathology in male mice and may be relevant in human disease.

overall_design: RNA profiles from lumbar spinal cord tissue of microglia Ager knockout mice, and Cre controls from an amyotrophic lateral sclerosis mouse model were compared.

first: Michael

last: MacLean

first: Judyta

last: Juranek

first: Swetha

last: Cuddapah

first: Raquel

last: López-Díez

first: Henry

middle: H

last: Ruiz

first: Jiyuan

last: Hu

first: Laura

last: Frye

first: Huilin

last: Li

middle: F

first: Ann Marie

last: Schmidt


title: Differentially expressed lncRNAs and mRNAs in primary human airway granulation fibroblasts before and after β-elemene treatment for 48h

city: Quanzhou

first: Yiming

last: Zeng

state: Fujian

address: Zhongshan North Road No.34, Licheng District

department: Department of Pulmonary and Critical Care Medicine, Respiratory Medicine Center of Fujian Province

institute: The Second Affiliated Hospital of Fujian Medical University

type:
Expression profiling by array
Non-coding RNA profiling by array

summary: There is an urgent need to identify effective medications to inhibit the abnormal airway granulation fibroblast activity, which plays a critical role in granulation tissue hyperplasia and scar formation during wound-healing after endobronchial intervention in the human airway, so as to prevent benign airway restenosis. Our previous study shown that β-elemene, a widely used effective ingredient of traditional Chinese medicine, effectively inhibited proliferation and survival of primary human airway granulation fibroblasts (PHAGF) in vitro, and promotes granulation tissue degeneration in vivo. To further investigate the mechanistic basis of these effects, we have employed LncRNA Microarray expression profiling as a discovery platform to identify differentially expressed lncRNAs and mRNAs in β-Elemene-treated PHAGF, thus enriching β-Elemene-altered pathway associated with cell proliferation and apoptosis, and thereby constructing a β-elemene-altered competitive endogenous RNAs (ceRNA) network that modulates this pathway. The results revealed ILK/Akt pathway, containing the upstream factor, ILK, the downstream cell cycle gene, Cyclin D1, and the anti-apoptosis gene, Bcl-2, were suppressed in β-Elemene-treated PHAGF. LncRNA-MIR143HG, which acts as a miR-1275 ceRNA to modulate ILK expression was also suppressed. Furhter validation via wet-lab experiments revealed that β-Elemene down-regulated LncRNA MIR143HG in PHAGF to reduce the competing sponging effect of MIR143HG on microRNA miR-1275, which targets upstream gene ILK in ILK/Akt pathway, thereby inducing the fibroblasts cell cycle arrest and apoptosis by suppressing ILK/Akt pathway.

overall_design: LncRNAs and mRNAs expressions in third-generation primary fibroblasts cultured from human airway hyperplastic granulation tissue resulting from prolonged intubation were measured with or without 160ug/ml β-elemene treatment for 48h, respectively. Three independent experiments were performed with or without β-elemene treatment.

first: Guoying

last: Zhang

first: Cheng

last: Xue


title: A time-course transcriptomic analysis during the cork growing season highlights the regulatory and developmental processes from phellogen to phellem formation

city: Girona

first: Olga

last: Serra

state: Girona

address: C/ Maria Aurèlia Capmany, 40

department: Biologia

country: Spain

institute: Universitat de Girona

summary: The phellogen or cork cambium is a bifacial stem cell population from which derivatives are formed by periclinal divisions and specified on opposing sides as phelloderm (inwardly) and phellem or cork (outwardly). Altogether the three layers constitute the periderm which covers and protects the radially-grown organs (stems, roots and tubers) and wounded tissues from dehydration and pathogen attack. The phellem is the final responsible of the protective function of periderm and despite its vital importance, just the suberin biosynthetic process has been studied molecularly while other processes are poorly understood. To shed some light on the phellem cell development from its formation to its final maturation, we used the innercork living material of cork planks extracted from cork oak (Quercus suber) in which we analysed the transcriptome at three time-points: at the beginning (April), maximum (June) and final (July) cork seasonal growth. Since cork presents seasonal growth and the process from phellogen derivative proliferation and specification to phellem cells is continuous, the time-course cork samples were used to approach the phellem cell formation and development. The June enrichment of phellem cells undergoing suberization was confirmed transcriptionally, observing highest expression of suberin-related genes in this month, thus validating our strategy. To highlight the major molecular processes embracing from phellogen to mature phellem cell, the differentially expressed genes between time-points were clustered based on their expression pattern. April transcriptome upregulates the processes involved in the meristem proliferation and maintenance and the triggering of cell differentiation, in agreement with the enrichment of phellogenic cells from which phellem cells are specified. The processes upregulated in Juny and July cork samples, were secondary metabolic processes compatible with the biosynthesis of secondary metabolites deposited within phellem cell wall such as suberin, lignin, extractives including fatty aciyl-derived compounds and triterpenes and also soluble aromatic compounds. The processes with a maximum in July showed upregulation of polyssacharides- and lignin-related processes compatible with a reinforcement of the cork cell wall, presumably related with the latecork formation with smaller and thickened-cells at the end of the growing season. For the above mentioned processes, we discuss the putative function of the most relevant genes in the context of phellem ontogeny. This work provides the most important molecular mechanisms during phellem cell development and provide relevant data for the understanding of the seasonal growth of cork, a material of important circular economic value.

overall_design: Sample: Innercork material (phellem + phellogenic tissue) of freshly-harvested virgin cork planks from cork oak (Quercus suber) trees growing naturally in Romanyà de la Selva (Girona, Spain).  Replicates: Each replicate was harvested from a different tree. 4 samples were from cork planks harvested in April, 3 samples harvested in June and 4 samples harvested in July.

first: Sandra

last: Fernández-Piñán

first: Pau

last: Boher

first: Marçal

last: Soler

first: Marisa

last: Molinas

first: Mercè

last: Figueras


title: Modeling Atrial Fibrillation (AF) in a Dish using Atrial iPSC-Derived Cardiomyocytes (iPSC-CMs)

city: Chicago

first: Leonid

last: Feferman

state: Illinois

address: 1737 West Polk St

department: Research Resources Center

institute: University of Illinois at Chicago

summary: Our study aims to illustrate the potential use of atrial iPSC-CMs for modeling AF in a dish, elucidating the underlying cellular mechanisms, and identifying novel mechanism-based therapies custom-tailored for individual patients

overall_design: We have 3 cell lines: Mutant A, Control A, Genomic-edit A. Each cell line has 2 samples, we plan to compare RNA-seq results in three cell lines

first: Mark

last: Maienschein-Cline

first: Jalees

last: Rehman

first: Liang

last: Hong


title: Effects of lenalidomide and/or imatinib treatment  on gene expression of  Ph-positive KOPN-57bi cells.

city: Setagaya-ku

first: NOBUTAKA

last: KIYOKAWA

state: Tokyo

department: Pediatric Hematology & Oncology Research

country: Japan

institute: National Research Institute for Child Health & Development

summary:
Even after the development of tyrosine kinase inhibitors (TKIs), the long-term prognosis of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) is still unsatisfactory, which is thought to be associated with the high incidence of genetic alterations of Ikaros family zinc finger 1 (IKZF1).  Lenalidomide (LEN), a representative of immunomodulatory drugs (IMiDs), has been effectively used for the treatment of relapsed/refractory multiple myeloma (MM), and its cytotoxic effect was recently shown to be mediated, at least in part, by marked down-regulation of IKZFs 1 and 3 expression through the interaction with the receptor cereblon (CRBN) forming a part of the Cullin-RING E3 ubiquitin ligase.  In the present study, we examined the effects of LEN on ALL cells with a variety of genetic alterations and found that Ph+ALL cells expressing a dominant-negative IKZF1 isoform Ik6 which lacks the CRBN binding site were specifically sensitive to LEN where accumulation of Ik6 with disappearance of functional IKZF1 isoforms and the abrupt fall from very high levels of IKZF3 expression were documented. To examine the effect of lenalidomide and/or imatinib treatment on Ph-positive ALL cells from the viewpoint of gene expression, we performed micro array analysis.
Of importance, the induction of apoptosis of Ph+ALL cells, even with the T315I mutation of BCR-ABL, was enhanced when they were treated with TKI in the presence of LEN.  This synergism between LEN and TKIs was demonstrated in the xenograft mice model.  IMiDs, now called as CRBN modulators, should be an attractive approach for potentiating responsiveness of Ph+ALL cells to TKIs, and this drug repositioning certainly facilitates their long-term survival if the effective combination regimen is warranted.

overall_design: The RNAs isolated from Ph-positive KOPN57bi cells cultured in the absence or presence of lenalidomide or imatinib alone or both were used for hybridization on Affymetrix microarrays.

first: Daisuke

last: Harama

first: Nobutaka

last: Kiyokawa

first: Kanji

last: Sugita


title: Effect of FGF10 on human Embryonic Stem Cells (hESC) and induced Pluripotent Stem Cells (hiPSC)

city: Giessen

first: Jochen

last: Wilhelm

state: Hessen

address: Aulweg 132

department: Institute for Lung Health

country: Germany

institute: Justus-Liebig University Giessen

summary: We wish to assess the transcritpomic regulation of FGF10 on human Embryonic Stem Cells (hESC) and human induced Pluripotent Stem Cells (hiPSC) that have been induced to express the earliest lung progenitor genetic marker, NKX2.1. Shortly after NKX2.1 was expressed in these cells, they were reseeded and FGF10 was added to the culture medium (experimental conditions) for either 12 or 24 hrs. Control samples had no FGF10 added. After the desired time, cells were harvested and stored in Trizol lysis buffer. RNA was extracted using a miRNeasy mini kit, and used for gene array analysis. Since this is a pilot experiment, we only have n=1 for experimental samples and n=1 for control samples for each condition.

overall_design: 8 groups, each with 1 biological replicates

first: Matthew

last: Jones


title: The DNA methylation Profile of Undifferentiated Arthritis Patients Anticipates their Subsequent Differentiation to Rheumatoid Arthritis

city: Badalona, Barcelona

first: Esteban

last: Ballestar

state: N/A = Not Applicable

address: Ctra de Can Ruti, Camí de les Escoles s/n

institute: Josep Carreras Research Institute (IJC)

summary: Undifferentiated arthritis (UA) is the term used to cover all the cases of arthritis that do not fit a specific diagnosis. A high proportion of UA patients can progress to rheumatoid arthritis (RA) or a different definite rheumatic disease, while others undergo spontaneous remission. In this study, we performed DNA methylation profiling of a UA cohort, in which progression into RA occurs for a significant proportion of the patients.

overall_design: Genome wide DNA methylation profiles were analyzed in peripheral blood mononuclear cells (PBMCs) from patients with undifferentiated arthritis (UA) in which, after one year of follow-up, a definite arthritis developed (rheumatoid arthritis (RA), psoriatic arthritis (PsA), osteoarthritis (OA), spondyloarthropathy (SpA) and reactive arthritis (ReA)). Additional PBMC samples from definite RA patients were also analyzed.

first: Carlos

last: de la Calle-Fabregat

first: Ellis

last: Niemantsverdriet

first: Juan

middle: D

last: Cañete

first: Tianlu

last: Li

first: Annette

last: van der Helm-van Mil

first: Javier

last: Rodríguez-Ubreva


title: Transcriptome analysis of mutations in plant nuclear membrane proteins PNET2A/B/C

city: Berkeley

first: Yangnan

last: Gu

state: CA

address: 371 Koshland Hall

department: Plant and Microbial Biology

institute: University of California at Berkeley

summary: Purpose: To understand the molecular mechanism underlying the severe phenotype caused by mutations in the plant nuclear membrane proteins PNET2_A/B/C, we performed the whole genome transcriptome analysis on 7-day-old seedlings of WT, pnet2_ac and pnet2_bc double mutant, and pnet2_abc triple mutant using RNA-seq.

overall_design: mRNA profiles of 7-day-old seedlings of wild type (Col-0), pnet2_ac and pnet2_bc double mutant, and pnet2_abc triple mutants were generated by deep sequencing, in triplicate, using Illumina HiSeq PE-150.

first: Yu

last: Tang


title: Minimized combinatorial CRISPR screens identify genetic interactions in autophagy

city: Frankfurt am Main

first: Manuel

last: Kaulich

state: Select...

address: Theodor-Stern-Kai 7, Bldg 75, Rm 0.222

department: Institute of Biochemistry II

institute: Goethe University Frankfurt

summary: Development of the 3Cs multiplex technology for combinatorial screening and identification of genetic interactions among human autophagy genes in cell proliferation and autophagy flux.

overall_design: mRNA profiles of human telomerase-immortalized retinal pigment epithelial cell line (hTERT-RPE1) expressing SpCas9 (CRISPRv2 vector, Addgene #52961)

first: Konstantin

last: Müller


title: RNA-seq of C18-4 and TM4 cells samples from different M5 receptor modification groups

city: Qingdao

first: Yong

last: Zhao

state: Shandong

address: 700 Changcheng Road

department: College of Life Sciences

institute: Qingdao Agricultural University

summary: The goat of this project is to explore M5 receptor  regulation spermatogenesis. We tried to search the mechanism of M5 receptor regulation spermatogenesis. RNA-seq of C18-4 and TM4 cells samples from different groups: C3NC,  M5 knockdown in C18-4, TM3NC,  M5 knockdown in TM4 cells.  The cell were transfected with virus with inhibition of M5 expression ( M5 gene knockdown).

overall_design: RNA-seq of C18-4 and TM4 cells samples from different groups: C3NC,  M5 knockdown in C18-4, TM3NC,  M5 knockdown in TM4 cells. The C18-4 and TM-4 cells  were transfected with virus with  inhibition of  M5 expression ( M5 gene knockdown).

first: Xiao

last: Han


first: Hu

state: MN

address: 200 First Street, Gonda Building G19-408

department: Molecular Pharmacology & Experimental Therapeutics

institute: Mayo Clinic

summary: RNAseq data for HGSOC PH039 PDXs at baseline and treated with cycles of 100 mg/kg niraparib for 21 days for four treatment rounds.

overall_design: RNAseq data of 12 samples (niraparib arm (n=3) or source tumor arm (n=2) ) in three independent experiments for four drug treaments cycles.

first: Scott

last: Kaufmann


title: Chromatin architectural proteins regulate flowering time by precluding gene looping

city: Austin

first: Bo

state: Texas

address: 2506 Speedway, NMS 5.268

department: Molecular Biosciences, Institute for Cellular and Molecular Biology

institute: The University of Texas

summary: We identified genes that could be regulated by HON4 and HON5 by using RNA-seq and ChIP-seq.

overall_design: Transcriptome analysis of genes regulated by HON4 and HON5. Genome-wide identification binding sites of HON5 by ChIP-seq.

first: Sibum

last: Sung


title: Pontin Functions as A Transcriptional Co-activator for Retinoic Acid-induced HOX Gene Expression [ChIP-seq]

city: San Antonio

first: Zhijie

middle: Jason

last: Liu

state: TEXAS

address: 7703 Floyd Curl Drive

department: Department of Molecular Medicine

institute: Universality of Texas Health Science Center at San Antonio

summary: Pontin is a AAA+ ATPase protein that has functions in various biological contexts including gene transcription regulation, chromatin remodeling, DNA damage sensing and repair, as well as assembly of protein and ribonucleoprotein complexes. Pontin is known to regulate the transcription of several important signaling pathways, including Wnt signaling. However, its role in early embryonic signaling regulation remains unclear. Retinoic acid (RA) signaling plays a central role in vertebrate development. Using an in vivo biotin tagging technology, we mapped the genome-wide binding pattern of Pontin before and after RA-induced differentiation in the pluripotent embryo carcinoma cell line NTEAR-2. Biotin ChIP-seq revealed significant changes in genome-wide Pontin binding sites upon RA stimulation. We also identified a substantial amount of overlapping binding peaks between Pontin and RARα, especially on all of the HOX gene loci (A-D clusters). Pontin knockdown experiments showed that its chromatin binding at the HOX gene clusters is required for RA-induced HOX gene expression. Furthermore, we performed Global Run-On sequencing (GRO-seq) to map de novo transcripts genome-wide and found that Pontin knockdown significantly diminished nascent HOX gene transcripts, indicating that Pontin regulates HOX gene expression at the transcriptional level. Finally, proteomic analysis demonstrated that Pontin associates with chromatin organization/remodeling complexes and various other functional complexes. Altogether, we have demonstrated that Pontin is a critical transcriptional co-activator for RA-induced HOX gene activation.

overall_design: Chromatin Immunoprecipitation (ChIP) assay followed by high throughput sequencing (ChIP-seq)

first: Zhang

first: Liu

last: Zhijie


title: Pontin Functions as A Transcriptional Co-activator for Retinoic Acid-induced HOX Gene Expression [GRO-seq]

overall_design: Global Run On (GRO) assay followed by high throughput sequencing (GRO-seq)


title: A pair of effectors in a conditionally dispensable chromosome of Fusarium oxysporum suppresses host-specific immunity

city: Yokohama

first: Shuta

last: Asai

address: 1-7-22, Suehiro-cho, Tsurumi-ku

institute: RIKEN

summary: In plant pathogenic fungi, conditionally dispensable (CD) chromosomes are often associated with virulence, but not viability. Such virulence-associated CD chromosomes carry genes encoding effectors and/or host-specific toxin biosynthesis enzymes, potentially important for determining host specificity. Fusarium oxysporum causes devastating diseases of more than 100 plant species. In particular, F. oxysporum f. sp. conglutinans (Focn) can infect Brassicaceae plants including Arabidopsis and cabbage. Here we show that Focn has multiple CD chromosomes involving in not only virulence but also vegetative growth, which is an atypical feature of known CD chromosomes. Among them, we identified specific CD chromosomes that are required for virulence to either Arabidopsis, cabbage, or both. We revealed that a pair of effectors encoded in one of the CD chromosomes is required for suppression of the Arabidopsis-specific phytoalexin-based immunity. The effector pair is highly conserved in F. oxysporum isolates capable of infecting Arabidopsis. This study provides insights into how host specificity of F. oxysporum is determined by a pair of effector genes on a CD chromosome.

sample_organism:
Arabidopsis thaliana
Brassica oleracea
Fusarium oxysporum

overall_design: For pre-incubation, Fusarium oxysporum f. sp. conglutinans Cong:1-1 (FocnCong:1-1) was incubated on potato dextrose agar (PDA) at 28°C under dark. For bud cell production, FocnCong:1-1 was grown in NO3 medium (0.17% yeast nitrogen base without amino acids, 3% sucrose and 1% KNO3) at 120 strokes per minute (spm) for 4 days at 28°C under dark. For expression profiling, mycelia were harvested after 10 days of incubation on PDA at 28°C. Bud cells were collected from the above culture in NO3 medium by filtration with a nylon mesh and centrifugation. Hyphae trapped with the nylon mesh were dried and collected. Mycelia (PDA), bud cells and hyphae were stored in a tube at -80°C until RNA isolation. In addition, 20 or 21 day-old Arabidopsis Col-0 and 17 day-old cabbage cv. Shosyu roots were irrigated with 1 ml of the FocnCong:1-1 bud cell suspension (1 × 10^7 cells/ml). At 3 dpi and 10 dpi, infected roots were washed with water to remove soil and then dried. The roots were stored in a tube at -80°C until RNA isolation. RNA sequencing was performed by deep sequencing on Illumina NextSeq 500 using a custom high-throughput method (Front Plant Sci 2012, 3:202). Each biological replicate set of samples were sequenced as one batch (biorep1, biorep2, biorep3, biorep4 and biorep5 in filenames).

last: Ayukawa

first: Arisa

last: Shibata

first: Yasunori

last: Ichihashi


title: The Cdk8 kinase module regulates Mediator-RNA polymerase II interaction

city: Göttingen

first: Eusra

last: Mohammad

address: Am Faßberg 11

institute: Max Planck Institute for Biophysical Chemistry

summary: The Cdk8 kinase module (CKM) is a dissociable part of the coactivator complex Mediator that regulates RNA polymerase II (Pol II transcription. The CKM has negative and positive functions in gene transcription that remain poorly understood at the mechanistic level. Here, we prepare recombinant CKM from the yeast Saccharomyces cerevisiae and show that it binds core Mediator (cMed) to sterically inhibit cMed binding to the Pol II preinitiation complex (PIC) in vitro. We further show that the Cdk8 kinase activity of CKM counteracts CKM-cMed interaction,thereby releasing CKM and enabling Mediator to bind the PIC. Finally, we report that the kinase activity of Cdk8 is required for gene activation during heat shock in vivo, but not under steady state growth conditions. These results converge with previous literature on a model for CKM function. In this model, CKM negatively regulates Mediator function at upstream activating sequences by preventing Mediator binding to the PIC at the promoter. During gene activation, Cdk8 kinase activity may release Mediator and allow its binding to the PIC, thereby stimulating transcription initiation and accounting for the positive function of CKM.

overall_design: 4tU-seq in yeast (Saccharomyces cerevisiae) Srb10 analogue-sensitive cells (Srb10 as-1) upon Srb10 inhibition

first: Sara

last: Osman

first: Kerstin

last: Maier

first: Michael

last: Lidschreiber

first: Patrick

last: Cramer


title: Pontin Functions as A Transcriptional Co-activator for Retinoic Acid-induced HOX Gene Expression

summary: This SuperSeries is composed of the SubSeries listed below.

overall_design: Refer to individual Series


title: Control Mint-ChIP-seq from CD8-positive, alpha-beta memory T cell (ENCSR996DNY)

status: Public on Jun 15 2021

city: Stanford

first: ENCODE

last: DCC

address: 300 Pasteur Dr

institute: ENCODE DCC

summary:
Control Mint-ChIP-seq on human CD8-positive, alpha-beta memory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from endothelial cell (ENCSR993KKI)

summary:
H3K36me3 Mint-ChIP-seq on human PGP1 derived endothelial cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from H9 (ENCSR998ZMN)

summary:
H3K27ac Mint-ChIP-seq on human H9

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from naive thymus-derived CD8-positive, alpha-beta T cell (ENCSR989YNV)

summary:
H3K36me3 Mint-ChIP-seq on human naive thymus-derived CD8-positive, alpha-beta T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from naive thymus-derived CD4-positive, alpha-beta T cell (ENCSR899DXS)

summary:
Control Mint-ChIP-seq on human naive thymus-derived CD4-positive, alpha-beta T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD4-positive, alpha-beta memory T cell (ENCSR898VJE)

summary:
H3K36me3 Mint-ChIP-seq on human CD4-positive, alpha-beta memory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD8-positive, alpha-beta memory T cell (ENCSR896PJY)

summary:
H3K36me3 Mint-ChIP-seq on human CD8-positive, alpha-beta memory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: miCLIP, RNA-Seq in HEK293E cells treated with Torin1

first: Brian

middle: Frederick

last: Pickering

state: New York

address: 1300 York Ave

department: Pharmacology

institute: Weill Cornell Medicine

summary: m6A RNA methylation and transcriptome profiling in were performed HEK293E cells following treatment with Torin1

overall_design: miCLIP and RNAseq was performed on twice poly(A)-purified mRNA from HEK293E cells that were serum starved overnight and treated with insulin (200 nM, 30h) with or without pretreatment of Torin1 (250 nM).  All experiments were performed in biological triplicate.

first: John

last: Blenis

first: Samie

last: Jaffrey


title: Mint-ChIP-seq from activated CD4-positive, alpha-beta memory T cell (ENCSR895OTJ)

summary: For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Tissue samples of 4 patients with esophageal cancer before and after radiotherapy

city: changzhou

first: Jianlin

last: Wang

state: jiangsu

address: Department of Radiotherapy, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical Univ

institute: hospital

summary:
Esophageal cancer is one of the common malignant tumors, and the mortality rate ranks fourth among all malignant tumors in China. Radiotherapy is one of the main methods for the treatment of esophageal cancer, and radiation resistance is one of the important factors of tumor recurrence and metastasis. Therefore, the study of radioresistance related markers of esophageal cancer is of great significance to improve the radiosensitivity of esophageal cancer.
We used microarrays to detail to find critical prognostic factors for esophageal cancer patients after radiotherapy.

overall_design: We screened out the differential genes before and after radiotherapy by expression microarray: select the tissue samples of the same patient before and after radiotherapy (radiotherapy to 40Gy, gastroscopy pathology, pathological report found squamous cell carcinoma), a total of 4 pairs of samples, a total of 8 cases. The samples were grouped and divided into pre-radiotherapy and post-radiotherapy.

first: Jing-Ping

last: Yu

first: Jian-Lin


title: Freeze-dried mouse sperm nucleus has tolerance against extreme environments

city: Chiba

first: Ryoko

last: Araki

address: Anagawa4-9-1, Inage-ku

institute: National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology

summary: To demonstrate the tolerance of mammalian sperm nucleus against extreme environments, mouse spermatozoa were freeze-dried and treated with 95 °C for 1 h or irradiated at over 5 Gy. Although all sperm were ostensibly dead after rehydration, healthy offspring were obtained from recovered sperm nuclei. The normality of those offspring were examined by microarray, and no difference were detected compare to fresh control offspring.

overall_design: Neonate brain derived from fresh spermatozoa, freeze-dried (FD) spermatozoa, 5 Gy X-ray irradiated FD spermatozoa and FD spermatozoa treated at 95 °C for 1 h were used.

first: Sayaka

last: Wakayama

first: Teruhiko


title: Genome-wide DNA methylation patterns in monocyte from patients with primary Sjögren’s syndrome

city: Beijing

first: Xuan

last: Luo

address: Dongcheng district

institute: Peking Union Medical College Hospital

type: Methylation profiling by genome tiling array

summary: To reveal the role of DNA methylation in peripheral monocytes (Mo) of primary Sjögren’s syndrome (pSS) patients, monocyte DNAs from 11 pSS patients and 5 matched controls were analyzed by methylation microarray.  In total, we identified 1977 hypomethylated and 842 hypermethylated differentially  methylated positions (DMPs) in Mo from pSS patients compared to healthy controls.

overall_design: Peripheral monocyte samples from 11 patients with pSS without treatment and 5 matched controls were analyzed by Illumina Infinium HumanMethylation850K BeadChip.

first: Yu

last: Peng

first: Yingying

last: Chen

first: Anqi

first: Chuiwen

last: Deng

first: Linyi

first: Qingjun

last: Wu

first: Yan

last: Zhao

first: Yunyun

last: Fei

first: Wen

last: Zhang


title: Mint-ChIP-seq from activated CD4 positive, naive alpha-beta T cell (ENCSR889GVN)

first: ENCODE


title: Mint-ChIP-seq from naive B cell (ENCSR987OPY)

summary:
H3K36me3 Mint-ChIP-seq on human naive B cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Tissue-specific transcriptional profiling of plasmacytoid dendritic cells reveals a hyperactivated state in chronic SIV infection

city: Atlanta

first: Steven

middle: E.

last: Bosinger

address: 954 Gatewood Rd NE

institute: Emory University

summary: HIV associated immune activation (IA) is associated with increased morbidity in people living with HIV (PLWH) on antiretroviral therapy, and remains a barrier for strategies aimed at reducing the HIV reservoir. The underlying mechanisms of IA have not been definitively elucidated, however, persistent production of Type I IFNs and expression of ISGs is considered to be one of the primary factors. Plasmacytoid DCs (pDCs) are a major producer of Type I IFN during viral infections, and are highly immunomodulatory in acute HIV and SIV infection, however their role in chronic HIV/SIV infection has not been firmly established. Here, we performed a detailed transcriptomic characterization of pDCs in chronic SIV infection in rhesus macaques, and in sooty mangabeys, a natural host non-human primate (NHP) species that undergoes non-pathogenic SIV infection. We also investigated the immunostimulatory capacity of lymph node homing pDCs in chronic SIV infection by contrasting gene expression of pDCs isolated from lymph nodes with those from blood. We observed that pDCs in LNs, but not blood, produced high levels of IFN transcripts, and upregulated gene expression programs consistent with T cell activation and exhaustion. We apply a novel strategy to catalogue uncharacterized surface molecules on pDCs, and identified the lymphoid exhaustion markers TIGIT and LAIR1 as highly expressed in SIV infection. pDCs from SIV-infected sooty mangabeys lacked the activation profile of ISG signatures observed in infected macaques. These data demonstrate that pDCs are a primary producer of Type I IFN in chronic SIV infection. Further, this study demonstrated that pDCs trafficking to LNs persist in a highly activated state well into chronic infection. Collectively, these data identify pDCs as a highly immunomodulatory cell population in chronic SIV infection, and a putative therapeutic target to reduce immune activation.

sample_organism:
Cercocebus atys
Macaca mulatta

platform_organism:
Cercocebus atys
Macaca mulatta

overall_design: RNA-Seq analysis of: (i) SIV+ vs SIV- rhesus macaque and sooty mangabey (n=4) (ii) PBMC vs LN in SIV+ rhesus macaques (n=9) (iii) spleen pDCs from H7N3+ vs H7N3- rhesus macaques (n=3)

first: Michelle

middle: Y

last: Lee

first: Amit

middle: A

last: Upadhyay

first: Hasse

last: Walum

first: Chi

middle: N

last: Chan

first: Reem

last: Dawoud

first: Christine

last: Grech

first: Justin

last: Harper

first: Kirti

last: Karunakaran

first: Sydney

last: Nelson

first: Ernestine

last: Mahar

first: Kyndal

last: Goss

first: Diane

middle: G

last: Carnathan

first: Barbara

last: Cervasi

first: Kiran

last: Gill

first: Gregory

last: Tharp

first: Elizabeth

last: Wonderlich

first: Vijayakumar

last: Velu

first: Simon

last: Barratt-Boyes

first: Mirko

last: Paiardini

first: Guido

last: Silvestri

first: Jacob

last: Estes

middle: E


title: Mint-ChIP-seq from CD8-positive, alpha-beta memory T cell (ENCSR884ROQ)

first: ENCODE

last: DCC

summary:
H3K9me3 Mint-ChIP-seq on human CD8-positive, alpha-beta memory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: MiRNA Expression in Glaucomatous and TGFb2 Treated Lamina Cribrosa cells

city: FORT WORTH

first: Tara

last: Tovar-Vidales

state: TX

address: 3500 Camp Bowie

department: Pharmacology & Neuroscience

institute: UNTHSC

summary: We determined the differential expression of miRNAs that target extracellular matrix mRNAs in glauocmatous and  TGFb2 treated lamina cribrosa cells compared to normal lamina cribrosa cells.

overall_design: The expression of miRNAs were analyzed using miRNA profiling using qPCR arrays.

first: Navita

last: Lopez

first: Rajiv

last: Rangan

first: Abbot

last: Clark


title: Mint-ChIP-seq from CD14-positive monocyte (ENCSR985RAJ)

summary:
H3K27me3 Mint-ChIP-seq on human CD14-positive monocyte

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: RNA-seq data of melon leaves and fruits at multiple developmental stages

city: College station

first: Hisashi

last: Koiwa

address: 495 Horticulture Rd.

department: Department of Horticultural Sciences

institute: Texas A&M University

summary: cDNA libraries of Melon leaves and fruits at the different stage

overall_design:
RNA sequencing using14-day-old leves (cultiver: F39) and fruits harvested at 20-25 days, 30-35 days, 40 and 45 days after flowering (cultiver: F39 and TTDV ).

Grant ID: USDA-NIFA-SCRI-2017-51181-26834
Grant title: TABLE TO FARM: A SUSTAINABLE, SYSTEMS-BASED APPROACH FOR A SAFER AND HEALTHIER MELON SUPPLY CHAIN IN THE U.S.
Name of funding source: National Institute of Food and Agriculture

first: Yukihiro

last: Nagashima

first: Kai

last: He

first: Xiaoning

last: Qian


title: RNA-seq based transcriptomic analysis of the non-conventional yeast Spathaspora passalidarum during Melle-boinot cell recycle in xylose-glucose mixtures

city: Campinas

first: Gabriela

last: Persinoti

state: São Paulo

address: Rua Giuseppe Máximo Scalfaro, 10.000

department: Brazilian Biorenewables National Laboratory LNBR

country: Brazil

institute: Brazilian Center for Research in Energy and Materials CNPEM

summary: The Mellet-boinot is a promising process to be applied for second-generation ethanol production by wild yeasts. However, the impact of this process on the physiology and fermentative performance of the xylose-fermenting yeast Spathaspora passalidarum during second-generation ethanol production, remains elusive. Therefore, we have conducted a deep transcriptomic analysis of S. passalidarum during five consecutive fed-batches and cell recycles, to determine the differences and global responses of differentially expressed genes (DEGs) during the Melle-Boinot process. A physiological adaptation was observed resulting in an increase on ethanol yield, ethanol volumetric productivity and ethanol titer. Furthermore, a decrease of the subproduct xylitol was also observed.  A transcriptional regulation was achieved from the third cell recycle onwards and this regulation was maintained afterwards. Analysing the DEGs during the recycles showed an up-regulation of  genes involved in ATP synthesis, N-Glycan biosynthesis, oxidative phosphorylation and purine metabolism, indicating as important mechanisms for adaptation throughout recycles due increased ethanol concentration. Moreover, the TCA cycle anabolic pathway, gluconeogenesis, glycogen and trehalose biosynthesis, fatty acid and sterol biosynthesis were also affected mainly due ethanol concentration and osmotic pressure implying that cell energy was generated towards the production of cell wall components in order to S. passalidarum cells to thrive in consecutive recycles. Taken together these results demonstrate that the Melle-Boinot process is a worthy strategy to be applied on 2G ethanol fermentation by native yeasts. Furthermore, we highlight major microbial molecular strategies for xylose conversion providing relevant insights for further metabolic engineering aiming to improve 2G bioethanol production.

overall_design: We have conducted a deep transcriptomic analysis of S. passalidarum during five consecutive fed-batches and cell recycles, to determine the differences and global responses of differentially expressed genes (DEGs) during the Melle-Boinot fermentation process.

first: Thiago

last: Neitzel

first: Cleilton

middle: S

last: Lima

first: Eduardo

last: Hafemann

first: Joaquim

last: Junior

first: Leandro

middle: V

last: dos Santos

first: Jaciane

last: Ienczak


title: Control Mint-ChIP-seq from naive thymus-derived CD8-positive, alpha-beta T cell (ENCSR881SIP)

summary:
Control Mint-ChIP-seq on human naive thymus-derived CD8-positive, alpha-beta T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from IgD-negative memory B cell (ENCSR983MKX)


title: WGS from transverse colon (ENCSR997HAI)

summary:
The library contained in this Experiment corresponds to 10X Genomics Chromium prepared WGS.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD14-positive monocyte (ENCSR991KBE)

summary:
H3K9me3 Mint-ChIP-seq on human CD14-positive monocyte

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from naive B cell (ENCSR884MVN)

summary:
H3K4me3 Mint-ChIP-seq on human naive B cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD4-positive naive resting alpha-beta T cell (ENCSR898DRE)

summary:
H3K9me3 ChIP-seq on CD4-positive naive resting alpha-beta T cell male adult (43 years)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from activated T-cell (ENCSR897COL)

summary:
Control Mint-ChIP-seq on activated T-cell male adult (38 years)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from CD8-positive, alpha-beta memory T cell (ENCSR890AQB)

summary:
Control Mint-ChIP-seq of CD8-positive, alpha-beta memory T cell male adult (30 years)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from brain (ENCSR988RUI)

summary:
H3K27ac Mint-ChIP-seq on human H9 derived brain organoid

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from naive thymus-derived CD4-positive, alpha-beta T cell (ENCSR977EPS)

summary:
H3K9me3 Mint-ChIP-seq on human naive thymus-derived CD4-positive, alpha-beta T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR976RWL)

summary:
H3K27ac Mint-ChIP-seq of activated CD8-positive, alpha-beta T cell male adult (30 years) treated with 10 ng

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD4-positive, alpha-beta memory T cell (ENCSR868SVG)

summary:
H3K36me3 Mint-ChIP-seq on human CD4-positive, alpha-beta memory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD4-positive, alpha-beta memory T cell (ENCSR975WTH)

summary:
H3K9me3 Mint-ChIP-seq on human CD4-positive, alpha-beta memory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from CD14-positive monocyte (ENCSR867UMZ)

summary:
Control Mint-ChIP-seq on human CD14-positive monocyte

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from activated CD4 positive, naive alpha-beta T cell (ENCSR865YWD)

summary:
H3K27me3 Mint-ChIP-seq of activated CD4-positive, alpha-beta T cell male adult (43 years) treated with anti-CD3 and anti-CD28 coated beads

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from activated T-cell (ENCSR975DSD)

summary:
Control Mint-ChIP-seq of activated T-cell male adult (42 years)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from CD4-positive, alpha-beta memory T cell (ENCSR887UYJ)

summary:
Control Mint-ChIP-seq on human CD4-positive, alpha-beta memory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD8-positive, alpha-beta memory T cell (ENCSR881AOK)

summary:
H3K4me3 Mint-ChIP-seq on human CD8-positive, alpha-beta memory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from naive thymus-derived CD4-positive, alpha-beta T cell (ENCSR878YHM)

summary:
H3K4me3 Mint-ChIP-seq on human naive thymus-derived CD4-positive, alpha-beta T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from brain (ENCSR978LBY)

summary:
H3K27ac Mint-ChIP-seq on human PGP1 derived brain organoid

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD8-positive, alpha-beta memory T cell (ENCSR869QEN)


title: Mint-ChIP-seq from immature natural killer cell (ENCSR977FMZ)

summary:
H3K27ac Mint-ChIP-seq on human immature natural killer cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control ChIP-seq from SK-N-SH (ENCSR973END)

summary:
ChIP-seq on human SK-N-SH

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: WGS from Caki2 (ENCSR969YUG)

summary: For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD8-positive, alpha-beta memory T cell (ENCSR861FEC)


title: Mint-ChIP-seq from activated CD4-positive, alpha-beta T cell (ENCSR969GTE)


title: Mint-ChIP-seq from IgD-negative memory B cell (ENCSR969UEM)


title: Control Mint-ChIP-seq from H9 (ENCSR854TWQ)

summary:
Control Mint-ChIP-seq on human H9

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from excitatory neuron (ENCSR864EXK)

summary:
H3K4me3 Mint-ChIP-seq on human PGP1 derived excitatory neuron

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from activated CD8-positive, alpha-beta T cell (ENCSR854MXR)

summary:
H3K36me3 Mint-ChIP-seq of activated CD8-positive, alpha-beta T cell male adult (21 years) treated with 10 ng

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from nephron (ENCSR862INW)

summary:
H3K4me3 Mint-ChIP-seq on human H9 derived nephron organoid

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: WGS from transverse colon (ENCSR961ZRM)

summary:
The data contained in this experiment correspond to Illumina-based whole genome shotgun sequencing of EN-TEX donor ENCDO793LXB, a 53 year old female. There are two libraries: PCR-based (9-cycle, ENCLB388OQF) and PCR-free (ENCLB358DLU), both sequenced on multiple lanes to a combined depth of ~ 60X in PE125 format.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD8-positive, alpha-beta memory T cell (ENCSR973KLH)

summary:
H3K36me3 Mint-ChIP-seq on human CD8-positive, alpha-beta memory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from activated CD8-positive, alpha-beta T cell (ENCSR958QJN)


title: Mint-ChIP-seq from nephron (ENCSR852EKS)

summary:
H3K4me1 Mint-ChIP-seq on human H9 derived nephron organoid

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from nephron (ENCSR850MVW)

summary:
H3K9me3 Mint-ChIP-seq on human H9 derived nephron organoid

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from naive thymus-derived CD4-positive, alpha-beta T cell (ENCSR954ZLD)


title: Control Mint-ChIP-seq from CD14-positive monocyte (ENCSR958CUX)

summary:
Control Mint-ChIP-seq on human CD14-positive monocyte

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from naive thymus-derived CD8-positive, alpha-beta T cell (ENCSR848XJL)

summary:
H3K4me3 Mint-ChIP-seq on human naive thymus-derived CD8-positive, alpha-beta T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD4-positive naive resting alpha-beta T cell (ENCSR953RGF)

summary:
H3K27me3 ChIP-seq on CD4-positive naive resting alpha-beta T cell male adult (43 years)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: WGS from whole organism (ENCSR971VTI)


title: Mint-ChIP-seq from CD4-positive, alpha-beta T cell (ENCSR855IYR)

summary:
H3K36me3 ChIP-seq on CD4-positive, alpha-beta T cell male adult (20 years)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control ChIP-seq from A549 (ENCSR855NLW)

summary:
ChIP-seq on human A549

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD4-positive, alpha-beta memory T cell (ENCSR959VZU)

summary:
H3K9me3 Mint-ChIP-seq on human CD4-positive, alpha-beta memory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from naive thymus-derived CD8-positive, alpha-beta T cell (ENCSR845VVI)

summary:
H3K27ac Mint-ChIP-seq on human naive thymus-derived CD8-positive, alpha-beta T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control ChIP-seq from K562 (ENCSR851OQN)

summary:
ChIP-seq on human K562

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from activated CD4-positive, alpha-beta T cell (ENCSR945GCR)

summary:
H3K27me3 Mint-ChIP-seq of activated CD4-positive, alpha-beta T cell male adult (20 years) treated with 10 ng

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from naive B cell (ENCSR945JTU)

summary:
H3K4me3 Mint-ChIP-seq on human naive B cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD4-positive naive resting alpha-beta T cell (ENCSR955IFA)

summary:
H3K36me3 ChIP-seq on CD4-positive naive resting alpha-beta T cell male adult (43 years)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD4-positive, alpha-beta memory T cell (ENCSR953STZ)

summary: For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from astrocyte (ENCSR941HLS)

summary:
H3K4me1 Mint-ChIP-seq on human PGP1 derived astrocyte

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from activated CD4 positive, naive alpha-beta T cell (ENCSR845GYI)

summary:
H3K27ac Mint-ChIP-seq of activated CD4-positive, alpha-beta T cell male adult (43 years) treated with anti-CD3 and anti-CD28 coated beads

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from immature natural killer cell (ENCSR835AVN)

summary:
H3K36me3 Mint-ChIP-seq on human immature natural killer cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from HFFc6 (ENCSR938NXC)

summary:
H3K9me3 Mint-ChIP-seq on human HFFc6

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from IgD-negative memory B cell (ENCSR832PIM)

summary:
H3K9me3 Mint-ChIP-seq on human IgD-negative memory B cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD4-positive, alpha-beta memory T cell (ENCSR935ELX)

summary:
H3K4me3 ChIP-seq on CD4-positive, alpha-beta memory T cell male adult (43 years)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from H9 (ENCSR931GAK)

summary:
Control Mint-ChIP-seq on human H9

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from brain (ENCSR844OQI)

summary:
H3K4me1 Mint-ChIP-seq on human PGP1 derived brain organoid

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from naive B cell (ENCSR931JYC)

summary:
H3K4me1 Mint-ChIP-seq on human naive B cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from naive B cell (ENCSR929MPF)

summary:
H3K9me3 Mint-ChIP-seq on human naive B cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD8-positive, alpha-beta T cell (ENCSR928PSU)

summary:
H3K27ac Mint-ChIP-seq of CD8-positive, alpha-beta T cell male adult (21 years)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from naive thymus-derived CD8-positive, alpha-beta T cell (ENCSR940PHE)

summary:
H3K4me1 Mint-ChIP-seq on human naive thymus-derived CD8-positive, alpha-beta T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from astrocyte (ENCSR835CSP)

summary:
H3K9me3 Mint-ChIP-seq on human PGP1 derived astrocyte

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from T-cell (ENCSR833OER)

summary:
H3K27ac ChIP-seq on T-cell male adult (38 years)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD4-positive, alpha-beta T cell (ENCSR833DCI)

summary:
H3K4me1 ChIP-seq on CD4-positive, alpha-beta T cell male adult (20 years)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from nephron progenitor cell (ENCSR943WLE)

summary:
H3K36me3 Mint-ChIP-seq on human H9 derived nephron progenitor cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from brain (ENCSR824UQL)

summary:
Control Mint-ChIP-seq on human H9 derived brain organoid

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD4-positive, alpha-beta memory T cell (ENCSR832UMM)

summary:
H3K27ac Mint-ChIP-seq on human CD4-positive, alpha-beta memory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from type B pancreatic cell (ENCSR943STF)

summary: For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from immature natural killer cell (ENCSR825ZXY)

summary:
H3K4me1 Mint-ChIP-seq on human immature natural killer cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control ChIP-seq from SK-N-SH (ENCSR922UWH)

summary:
ChIP-seq on human SK-N-SH

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from naive B cell (ENCSR821WMA)


title: Mint-ChIP-seq from naive B cell (ENCSR935ULD)

summary:
H3K36me3 Mint-ChIP-seq on human naive B cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from IgD-negative memory B cell (ENCSR831AXK)


title: Mint-ChIP-seq from IgD-negative memory B cell (ENCSR923EGO)

summary:
H3K4me3 Mint-ChIP-seq on human IgD-negative memory B cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from GM23338 (ENCSR828GHL)

summary:
H3K9me3 Mint-ChIP-seq on human GM23338

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from naive thymus-derived CD8-positive, alpha-beta T cell (ENCSR923JIB)

summary:
H3K27ac Mint-ChIP-seq on human naive thymus-derived CD8-positive, alpha-beta T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from CD4-positive, alpha-beta memory T cell (ENCSR934ZBY)

summary:
Control Mint-ChIP-seq on human CD4-positive, alpha-beta memory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD4-positive, alpha-beta memory T cell (ENCSR830YQW)


title: Control Mint-ChIP-seq from CD8-positive, alpha-beta T cell (ENCSR820SXH)

summary:
Control Mint-ChIP-seq of CD8-positive, alpha-beta T cell male adult (21 years)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from excitatory neuron (ENCSR818PER)

summary:
H3K27ac Mint-ChIP-seq on human PGP1 derived excitatory neuron

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD14-positive monocyte (ENCSR821CPA)

summary:
H3K27ac Mint-ChIP-seq on human CD14-positive monocyte

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD4-positive, alpha-beta memory T cell (ENCSR919DFZ)

summary:
H3K9me3 Mint-ChIP-seq on human CD4-positive, alpha-beta memory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from CD4-positive, alpha-beta memory T cell (ENCSR817QVK)

summary:
Control Mint-ChIP-seq on CD4-positive, alpha-beta memory T cell male adult (43 years)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control ChIP-seq from K562 (ENCSR825BVU)

summary:
ChIP-seq on human K562

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from CD4-positive, alpha-beta memory T cell (ENCSR917PCR)


title: Control ChIP-seq from K562 (ENCSR816YLP)


title: Mint-ChIP-seq from CD8-positive, alpha-beta memory T cell (ENCSR815YZL)

summary:
H3K4me1 Mint-ChIP-seq on human CD8-positive, alpha-beta memory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control ChIP-seq from K562 (ENCSR915XAG)


title: Mint-ChIP-seq from CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR914UYO)

summary:
H3K36me3 Mint-ChIP-seq on human CD4-positive, CD25-positive, alpha-beta regulatory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from nephron (ENCSR814PLO)

summary:
H3K4me1 Mint-ChIP-seq on human H9 derived nephron organoid

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD14-positive monocyte (ENCSR813FVY)

summary:
H3K4me1 Mint-ChIP-seq on human CD14-positive monocyte

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from B cell (ENCSR812IND)

summary: For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from activated CD4-positive, alpha-beta memory T cell (ENCSR813EKK)


title: Control Mint-ChIP-seq from IgD-negative memory B cell (ENCSR808EUQ)

summary:
Control Mint-ChIP-seq on human IgD-negative memory B cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from naive B cell (ENCSR910RFG)

summary:
H3K27ac Mint-ChIP-seq on human naive B cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from progenitor cell of endocrine pancreas (ENCSR922UKO)

summary:
H3K27ac Mint-ChIP-seq of progenitor cell of endocrine pancreas originated from progenitor cell of endocrine pancreas

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from activated CD4-positive, alpha-beta T cell (ENCSR911DCW)


title: Mint-ChIP-seq from naive thymus-derived CD4-positive, alpha-beta T cell (ENCSR807NUW)

summary:
H3K4me1 Mint-ChIP-seq on human naive thymus-derived CD4-positive, alpha-beta T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from naive B cell (ENCSR906UGW)

summary:
Control Mint-ChIP-seq on human naive B cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control ChIP-seq from K562 (ENCSR906GHW)


title: Mint-ChIP-seq from CD4-positive, alpha-beta memory T cell (ENCSR807AXH)

summary:
H3K4me1 Mint-ChIP-seq on human CD4-positive, alpha-beta memory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from endodermal cell (ENCSR901NYG)

summary:
Control Mint-ChIP-seq on human H9 derived endodermal cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD4-positive, alpha-beta memory T cell (ENCSR802MXQ)

summary:
H3K4me3 Mint-ChIP-seq of CD4-positive, alpha-beta memory T cell originated from CD4-positive, alpha-beta memory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: microRNA-seq from GM23338 (ENCSR804CAP)

type: Non-coding RNA profiling by high throughput sequencing

summary:
RNA Evaluation PGP1 iPSC microRNA-seq from Mortazavi

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from brain (ENCSR804EYS)

summary:
H3K27me3 Mint-ChIP-seq on human H9 derived brain organoid

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from nephron (ENCSR801AJD)

summary:
Control Mint-ChIP-seq on human H9 derived nephron organoid

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from naive B cell (ENCSR900IAM)

summary:
H3K4me1 Mint-ChIP-seq on human naive B cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from CD4-positive naive resting alpha-beta T cell (ENCSR692OOM)

summary:
Control Mint-ChIP-seq on CD4-positive naive resting alpha-beta T cell male adult (43 years)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: WGS from Panc1 (ENCSR696BCR)


title: Mint-ChIP-seq from activated T-cell (ENCSR696ILA)

summary:
H3K27me3 ChIP-seq on activated T-cell male adult (38 years)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from naive thymus-derived CD4-positive, alpha-beta T cell (ENCSR688UBO)

summary:
Control Mint-ChIP-seq on human naive thymus-derived CD4-positive, alpha-beta T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD4-positive, alpha-beta memory T cell (ENCSR696DVE)

summary:
H3K27ac Mint-ChIP-seq on human CD4-positive, alpha-beta memory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from activated CD8-positive, alpha-beta T cell (ENCSR689XCY)

summary:
H3K36me3 Mint-ChIP-seq of activated CD8-positive, alpha-beta T cell male adult (21 years) treated with anti-CD3 and anti-CD28 coated beads

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from naive thymus-derived CD4-positive, alpha-beta T cell (ENCSR687CQX)


title: Mint-ChIP-seq from activated CD4 positive, naive alpha-beta T cell (ENCSR685XAS)

summary: For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from nephron progenitor cell (ENCSR688KJU)

summary:
H3K9me3 Mint-ChIP-seq on human H9 derived nephron progenitor cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD14-positive monocyte (ENCSR685BBN)

summary:
H3K27ac Mint-ChIP-seq on human CD14-positive monocyte

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from activated B cell (ENCSR685KZA)

summary:
H3K27ac ChIP-seq on B cell male adult (22 years)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control ChIP-seq from K562 (ENCSR682TOC)

summary:
ChIP-seq on human K562

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from activated CD8-positive, alpha-beta T cell (ENCSR801PPM)


title: Mint-ChIP-seq from nephron progenitor cell (ENCSR682SDS)

summary:
H3K4me3 Mint-ChIP-seq on human H9 derived nephron progenitor cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control ChIP-seq from NCI-H929 (ENCSR698TWO)

summary:
ChIP-seq on human NCI-H929

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD14-positive monocyte (ENCSR677ZMY)

summary:
H3K4me1 Mint-ChIP-seq on human CD14-positive monocyte

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD14-positive monocyte (ENCSR799KCK)

summary:
H3K9me3 Mint-ChIP-seq on human CD14-positive monocyte

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control ChIP-seq from A549 (ENCSR676KGV)

summary:
ChIP-seq on human A549

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from H9 (ENCSR681HPO)

summary:
H3K36me3 Mint-ChIP-seq on human H9

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from activated CD4-positive, alpha-beta T cell (ENCSR674JPB)

summary:
Control Mint-ChIP-seq of activated CD4-positive, alpha-beta T cell male adult (20 years) treated with anti-CD3 and anti-CD28 coated beads

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from nephron progenitor cell (ENCSR792LOV)

summary:
H3K4me1 Mint-ChIP-seq on human H9 derived nephron progenitor cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: WGS from GM23248 (ENCSR674PQI)

summary:
The data contained in this experiment correspond to Illumina-based whole genome shotgun sequencing of the Personal Genomes Project 1 donor (PGP1) donor ENCDO336AAA. They were made using a PCR-based (9-cycle, ENCLB234AQO) protocol sequenced on multiple lanes to a combined depth of ~ 60X in PE125 format.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from activated T-cell (ENCSR677RWJ)

summary:
H3K4me1 ChIP-seq on activated T-cell male adult (38 years)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control ChIP-seq from K562 (ENCSR673WPR)


title: Mint-ChIP-seq from activated B cell (ENCSR791CAF)

summary:
H3K4me3 ChIP-seq on B cell male adult (22 years)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control ChIP-seq from SK-N-SH (ENCSR670GWL)

summary:
SK-N-SH immortalized cell line (treated with 6 uM all-trans-retinoic acid for 48 hours) stably expressing C-terminal eGFP-ZSCAN18 fusion protein.

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD14-positive monocyte (ENCSR790KDX)

summary:
H3K36me3 Mint-ChIP-seq on human CD14-positive monocyte

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control ChIP-seq from K562 (ENCSR667UGH)


title: Mint-ChIP-seq from endodermal cell (ENCSR788UDH)

summary:
H3K4me3 Mint-ChIP-seq on human H9 derived endodermal cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD14-positive monocyte (ENCSR787IEM)


title: Mint-ChIP-seq from naive thymus-derived CD8-positive, alpha-beta T cell (ENCSR788TEF)

summary: For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from T-cell (ENCSR789VME)

summary:
H3K9me3 ChIP-seq on T-cell male adult (38 years)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from GM23338 (ENCSR787HYA)

summary:
Control Mint-ChIP-seq on human GM23338

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD8-positive, alpha-beta memory T cell (ENCSR787HDF)

summary:
H3K27ac Mint-ChIP-seq on human CD8-positive, alpha-beta memory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from activated B cell (ENCSR784EZW)

summary:
Control Mint-ChIP-seq on B cell male adult (22 years)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from naive thymus-derived CD4-positive, alpha-beta T cell (ENCSR785PKM)

summary:
H3K36me3 Mint-ChIP-seq on human naive thymus-derived CD4-positive, alpha-beta T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from activated CD4-positive, alpha-beta T cell (ENCSR779CPT)

summary:
Control Mint-ChIP-seq of activated CD4-positive, alpha-beta T cell male adult (20 years) treated with 10 ng

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD14-positive monocyte (ENCSR663IRI)

summary:
H3K4me1 Mint-ChIP-seq on human CD14-positive monocyte

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from naive thymus-derived CD8-positive, alpha-beta T cell (ENCSR780GTM)

summary:
H3K36me3 Mint-ChIP-seq on human naive thymus-derived CD8-positive, alpha-beta T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from nephron (ENCSR783VHL)

summary:
H3K4me3 Mint-ChIP-seq on human H9 derived nephron organoid

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD4-positive, alpha-beta memory T cell (ENCSR657PXQ)

summary:
H3K4me3 Mint-ChIP-seq on human CD4-positive, alpha-beta memory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from brain (ENCSR776FPA)

summary:
H3K27ac Mint-ChIP-seq on human PGP1 derived brain organoid

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from brain (ENCSR660QRP)

summary:
H3K9me3 Mint-ChIP-seq on human PGP1 derived brain organoid

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from IgD-negative memory B cell (ENCSR651XKR)

summary:
H3K27me3 Mint-ChIP-seq of IgD-negative memory B cell originated from IgD-negative memory B cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from activated CD8-positive, alpha-beta T cell (ENCSR651JZJ)

summary:
Control Mint-ChIP-seq of activated CD8-positive, alpha-beta T cell male adult (21 years) treated with 10 ng

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: WGS from NCI-H460 (ENCSR654YMF)


title: Mint-ChIP-seq from CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR774HOA)

summary:
H3K4me1 Mint-ChIP-seq on human CD4-positive, CD25-positive, alpha-beta regulatory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from naive thymus-derived CD8-positive, alpha-beta T cell (ENCSR652WFO)


title: Mint-ChIP-seq from CD8-positive, alpha-beta memory T cell (ENCSR650DHK)

summary:
H3K4me1 Mint-ChIP-seq on human CD8-positive, alpha-beta memory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from CD4-positive, alpha-beta T cell (ENCSR774CGN)

summary:
Control Mint-ChIP-seq on CD4-positive, alpha-beta T cell male adult (20 years)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control ChIP-seq from lung (ENCSR645ZNG)

summary:
Reverse Crosslink Control ChIP-seq on postnatal 0 day mouse lung (fragmentation date 05-28-14)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from activated CD8-positive, alpha-beta T cell (ENCSR772DTU)

summary:
H3K27me3 Mint-ChIP-seq of activated CD8-positive, alpha-beta T cell male adult (21 years) treated with anti-CD3 and anti-CD28 coated beads

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from activated CD4-positive, alpha-beta memory T cell (ENCSR764KHZ)

summary:
H3K36me3 Mint-ChIP-seq of activated CD4-positive, alpha-beta T cell male adult (43 years) treated with anti-CD3 and anti-CD28 coated beads

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from activated CD8-positive, alpha-beta T cell (ENCSR765BUP)

summary:
H3K27me3 Mint-ChIP-seq of activated CD8-positive, alpha-beta T cell male adult (21 years) treated with 10 ng

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from activated CD4 positive, naive alpha-beta T cell (ENCSR765ULM)

summary: For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Control Mint-ChIP-seq from CD8-positive naive resting alpha-beta T cell (ENCSR761HQT)

summary:
Control Mint-ChIP-seq of CD8-positive naive resting alpha-beta T cell male adult (30 years)

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf


title: Mint-ChIP-seq from CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR769FEY)

summary:
H3K27ac Mint-ChIP-seq on human CD4-positive, CD25-positive, alpha-beta regulatory T cell

For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf